Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ZFGN

Zafgen (ZFGN) Stock Price, News & Analysis

Zafgen logo

About Zafgen Stock (NASDAQ:ZFGN)

Key Stats

Today's Range
$4.04
$4.41
50-Day Range
$0.99
$25.06
52-Week Range
$0.62
$2.76
Volume
2.13 million shs
Average Volume
360,199 shs
Market Capitalization
$159.25 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ZFGN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Zafgen and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ZFGN Stock News Headlines

Tokyo Steel Manufacturing Co Ltd 5423
Buy this stock before Tesla’s November 6 announcement
The End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff, as the world's biggest car firm prepares to launch a "mind blowing" new product. It has nothing to do with EVs, or self-driving cars. In fact, it's not a car at all...tc pixel
Food and drink in a castle
LRMR Larimar Therapeutics, Inc.
Form 424B5 Larimar Therapeutics, - StreetInsider.com
See More Headlines

ZFGN Stock Analysis - Frequently Asked Questions

Zafgen Inc (NASDAQ:ZFGN) issued its earnings results on Thursday, March, 5th. The biopharmaceutical company reported ($0.19) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.19).

Based on aggregate information from My MarketBeat watchlists, some other companies that Zafgen investors own include Xtrackers California Municipal Bond ETF (CA), Bristol Myers Squibb (BMY), Endologix (ELGX), Energy Transfer (ET), BlackRock (BLK), TG Therapeutics (TGTX) and SCYNEXIS (SCYX).

Company Calendar

Last Earnings
3/05/2020
Today
10/13/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:ZFGN
CIK
1374690
Fax
N/A
Employees
38
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($1.07)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$45.41 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-51.34%
Return on Assets
-34.55%

Debt

Debt-to-Equity Ratio
0.26
Current Ratio
6.56
Quick Ratio
6.56

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.35 per share
Price / Book
3.23

Miscellaneous

Outstanding Shares
37,470,000
Free Float
N/A
Market Cap
$163.37 million
Optionable
Not Optionable
Beta
0.27
Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:ZFGN) was last updated on 10/14/2025 by MarketBeat.com Staff
From Our Partners